O

Outlook Therapeutics

D
OTLK
USD
0.07
(1.1804%)
Market Closed
5,727.00
Volume
-3.98
EPS
-
Div Yield
-1.018676
P/E
141,933,816.00
Market Cap
Today
1.1804%
1 Week
-7.264%
1 Month
-16.318%
6 Months
-19.028%
12 Months
32.392%
Year To Date
-24.051%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CTSO
0.04
(2.8369%)
USD
H
HOOK
-0.06
(-1.2685%)
USD
O
OCGN
0.025
(2.2422%)
USD
O
ORTX
(%)
USD
O
OPCH
0.48
(1.5439%)
USD
S
SNDX
0.61
(3.387%)
USD
T
TLGT
(%)
USD

Title:
Outlook Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Do you need help or have a question?
Contact Us